Description
PAY VENDOR FINAL INVOICE - CLOSE OUT. NITRIC OXIDE USAGE
Base award description: IGF::OT::IGF NITRIC OXIDE USAGE
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-01+$65,277= $65,277
- Mod P000012019-10-04-$62,326= $2,951
- Mod P000022020-10-05+$37,271= $40,222
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-01 | +$65,277 | $65,277 | IGF::OT::IGF NITRIC OXIDE USAGE |
| Mod P00001· CLOSE OUT | 2019-10-04 | −$62,326 | $2,951 | DE-OBLIGATE FUNDS FOR CLOSE OUT. NITRIC OXIDE USAGE |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2020-10-05 | +$37,271 | $40,222 | PAY VENDOR FINAL INVOICE - CLOSE OUT. NITRIC OXIDE USAGE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SJ9MSB1UXGL8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0786 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $4,435 | FY2026 |
| 36C24526N0382 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $5,213 | FY2026 |
| 36C24525N0842 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $5,572 | FY2025 |
| 36C24525N0365 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $5,328 | FY2025 |
| 36C24524N0852 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $4,639 | FY2024 |
| 36C24524N0407 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $4,884 | FY2024 |
Other recipients under Q501 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726N0137 | TITAN-AUXO, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $3,326,721 | FY2026 |
| 36C24721P1101 | GENERAL ELECTRIC COMPANY | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $10,997 | FY2021 |
| 36C24720P0438 | RAS ENTERPRISES LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $1,067,533 | FY2020 |
| 36C24720F0001 | INO THERAPEUTICS LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $79,596 | FY2020 |
| VA24717C0045 | LINDE GAS & EQUIPMENT INC. | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $164,394 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24718F0001_3600_V797D40177_3600 · retrieved 2026-09-26.